27-28 November 2024
ENS – Lyon, France
The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.
I4ID2024 will build on the successes of the previous editions, the first one starting in 2017, that counted with the presence of more than 1520 participants from different countries representing over 500 organizations and 265 internationally renowned speakers exchanging on immunotherapy and new therapeutic approaches to fight infectious diseases.
The I4ID2024 will include keynote lectures, pitch talks of new innovative projects, industrial talks from pharmaceutical companies and poster presentations.
Moreover, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering, through an online B2B platform.